Isotype Control Antibodies
AFP110-Beinaglutide
0102030405
- +1 609-736-0910
- info@alphalifetech.com
- 90 State Street, STE 700 Office 40, Albany, NY 12207 United States
Product Background
Due to its identical structure to native GLP-1, Beinaglutide maintains a relatively short half-life in the bloodstream and is typically administered via multiple daily injections. This pharmacokinetic profile allows it to closely simulate the natural pulsatile secretion of GLP-1 following meals. Clinically, it is utilized to manage body weight and glycemic control by suppressing appetite through central nervous system signaling and reducing caloric intake without the increased risk of hypoglycemia associated with non-glucose-dependent therapies.
Catalog Number |
AFP110 |
Product Name |
AFP110-Beinaglutide |
Molecular Formula |
C₁₄₉H₂₂₅N₃₉O₄₆ |
Molecular Weight |
3298.7 Da |
Structural formula |
H-A-E-G-T-F-T-S-D-V-S-S-Y-L-E-G-Q-A-A-K-E-F-I-A-W-L-V-K-G-R-OH |
CAS Accession |
123475-27-4 |
Size |
1mg, 5mg, 100mg, bulk |
Storage Condition |
Cool dry place(-20±5℃,Keep away from acids and alkali) |
Purity |
>98% |
Purification |
HPLC |
Endotoxin |
< 5 EU/mg |
Reconstitution Conditions |
Reconstitute in ddH2O for a stock solution. |
Shipping Condition |
This product is shipped on ice packs. |
Note |
For Research Use Only! |